# Evaluation of the Clinical Impact of Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)

> **NCT05595031** · — · UNKNOWN · sponsor: **Methodist Health System** · enrollment: 400 (estimated)

## Conditions studied

- Covid 19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05595031
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-19
- **Primary completion:** 2023-10-19
- **Final completion:** 2023-10-19
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05595031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05595031, "Evaluation of the Clinical Impact of Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05595031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*